Skip to main content
Full access
Letter to the Editor
Published Online: 7 June 2002

Different Kind of CME Needed

The March 1 issue carried a report on a Lilly-funded study comparing fluoxetine, paroxetine, and sertraline. The conclusion was that these three “best-selling SSRIs are nearly indistinguishable as first-line treatments of depression in primary care.” The outcome “surprised” the primary care physicians involved.
Sadly, this “surprise” reflects our vulnerability to the well-crafted advertising efforts of the pharmaceutical industry. Many writers have noted the incredible skill and sophistication of the advertising business, whether it is selling political candidates or beer or soap. It is no surprise that medicine and doctors fall prey to these skills.
As physicians we are shown glossy, well-designed charts and presentations depicting the “clear” advantages of one medication over the others. This information is presented by skilled and often pleasant drug representatives who often offer food along with their message. Perhaps even more insidious is the article or “free” CME insert on “treatment of bipolar disorder” and so on. In these “unrestricted” educational presentations, there is often a not-too-subtle bias toward a particular medication featured by the pharmaceutical underwriter. We are led to believe that the data are objective, and “statistics” don’t lie. We know, however, that in the presentation of data and statistical information there is considerable room for crafting the presentation and selecting data to “prove” a point. One needs to be well versed in statistical analysis and experimental-design analysis to truly decipher the glossy presentations. Most of us lack these high-level skills.
What we need is the introduction of seminars in numerous CME venues focusing on the understanding and analysis of the pharmaceutical/pharmacological “information” flooding our professional lives. Perhaps these should be mandated in the same way that risk management CME credits are required. The role of advertising in psychiatric practice is not going to change except to become more intrusive and pervasive. We need to be trained more effectively to understand it and protect our practice of medicine.

Information & Authors

Information

Published In

History

Published online: 7 June 2002
Published in print: June 7, 2002

Authors

Details

Paul Redstone, M.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share